SCHEDULE: Vanguard Discloses 6.57% Stake in Silicon Labs

Vanguard Portfolio Management has reported a beneficial ownership of 6.57% in Silicon Laboratories Inc. common stock as of March 31, 2026.

Summary

• Vanguard Portfolio Management, along with its affiliates Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC, now beneficially owns 2,167,187 shares of Silicon Laboratories Inc. common stock.
• This holding represents 6.57% of the class of securities.
• The filing indicates that Vanguard Portfolio Management has sole dispositive power over 2,167,187 shares and sole voting power over 28,351 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by a large institutional investor and does not contain operational or financial performance data for Silicon Laboratories Inc.

Positives

• Vanguard's significant stake suggests confidence in Silicon Laboratories' long-term prospects.
• The reporting is in accordance with standard Schedule 13G filings, indicating compliance and transparency.

Risks

• While not explicitly stated as a risk in this filing, a large institutional holder like Vanguard could potentially influence corporate strategy or governance decisions.
• The filing does not provide details on the specific reasons for acquiring this stake, leaving room for speculation about Vanguard's investment thesis.

Future Outlook

This filing is a snapshot of ownership as of March 31, 2026, and does not contain forward-looking statements or guidance from Silicon Laboratories Inc. itself. It reflects Vanguard's current investment position.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major asset manager like Vanguard typically indicates a passive investment strategy, focusing on portfolio diversification and long-term value rather than active control. This filing suggests Vanguard views Silicon Laboratories as a significant holding within its investment portfolios.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be seen as a positive signal of confidence, potentially influencing market perception.
• Management of Silicon Laboratories Inc.: While Vanguard's stake is passive, its size means the company will be mindful of maintaining performance and governance standards that align with large institutional investor expectations.

Next Steps

• Vanguard will continue to hold or adjust its position in Silicon Laboratories Inc. common stock based on its investment strategy.
• Silicon Laboratories Inc. will continue its business operations and financial reporting as usual.

Key Dates

Keywords

Silicon Laboratories Inc, Vanguard Portfolio Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing